Scientific Presentations

Listen and view the various scientific presentations captured during our events held throughout the years.


Advancing clinical SPECT/CT: Integrating routine use with theranostic growth | Symposium at SNMMI 2025

 23.06.2025

Toni Bamford, CNMT, ARRT (CT), NMTCB RS (Radiation Safety), NCT, PeaceHealth, Springfield, Oregon, USA

SNMMI 2025

PET amyloid imaging in clinical trials | Vendor Workshop at RSNA 2024

 23.04.2025

Jacob Dubroff, MD, PhD, associate professor of radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

​RSNA 2024

Amyloid PET in the diagnosis and management of patients with suspected Alzheimer disease | Vendor Workshop at RSNA 2024

 23.04.2025

Jana Ivanidze, MD, PhD, associate professor of radiology, Weill Cornell Medical College, New York, New York, USA

RSNA 2024

The exploration of ultra-low dose PET/CT and its implications for patient care | Vendor Workshop at RSNA 2024

 23.04.2025

Eliot Siegel, MD, medical director at United Theranostics, Minneapolis, Minnesota, USA

RSNA 2024

A powerful bond for cancer treatment: Incorporating molecular imaging with nuclear therapeutics | Vendor Workshop at RSNA 2024

 03.04.2025
Ryan Avery, MD, director of nuclear medicine, Northwestern Medicine, Chicago, Illinois, USA.
RSNA 2024

Biograph Trinion PET/CT Future-forward by design | Symposium at EANM 2024

 20.10.2024

Sebastian Fuerst, PhD, product manager, Siemens Healthineers, Molecular Imaging, Knoxville, Tennessee, USA

EANM 2024

Biograph Vision Quadra: A change agent for molecular imaging | Symposium at EANM 2024

 20.10.2024

Daniel McCool, PhD, head of nuclear medicine, Royal Free Hospital, London, United Kingdom

EANM 2024

Advanced solutions in molecular imaging: Peritherapeutic theranostics | Symposium at EANM 2024

 20.10.2024

Friederike Eilsberger, MD, senior physician, Department of Nuclear Medicine, University Hospital Marlburg, Marlburg, Germany

EANM 2024

NIST-traceable fast quantitative SPECT/CT imaging of Lu-177: Personalized radiopharmaceutical therapy with Symbia Pro.specta | Symposium at SNMMI 2024

 11.06.2024

Michael Morris, MD, MS, co-founder physician, United Theranostics, Glen Burnie, Maryland, USA

SNMMI 2024

Biograph Trinion PET/CT: First user experience | Symposium at SNMMI 2024

 10.06.2024

Betty Harrell, R.T.(R)(N)(ARRT), lead nuclear medicine technologist and Russell L. Roberts, Jr, MD, nuclear medicine physician, Rome Imaging Center, Rome, Georgia, USA

SNMMI 2024

Prostate cancer radiopharmaceutical therapy: Beyond the basic | Vendor Workshop at RSNA 2023

 28.11.2023

Joseph R. Osborne, MD, PhD, Chief, Molecular Imaging and Therapeutics, Professor of Radiology, Director of the Radiology Health Equity Lab at New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New. York, USA.

RSNA 2023

PSMA PET: Technical and clinical case review | Vendor Workshop at RSNA 2023

 26.11.2023

Nicholas Feinberg, MD, Assistant Professor of Radiology, University of Chicago Medicine, Chicago, Illinois, USA.

RSNA 2023

Timing is of the essence: Unlocking the potential of PET/CT imaging with time of flight

 28.09.2023

Dr. Ian Armstrong, Nuclear Medicine Consultant Physicist, Manchester University NHS Foundation Trust, United Kingdom.

Transitioning to next-generation SPECT/CT | Symposium at EANM 2023

 10.09.2023

Juho Kuukasjärvi, radiographer, and Joni Granlund, radiographer, Oulu University Hospital, Oulu, Finland

EANM 2023

The potential Impact of Total Body PET to Whole Person Research and Network Medicine

 09.09.2023

Discover how Prof. Dr. Marcus Hacker envisions the potential of Total Body PET for whole person research and its effects on network medicine. 

EANM 2023